What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Nov. 9, 2015, 10:17 AM
Nov. 9, 2015, 9:17 AM
Aug. 6, 2015, 4:26 PM
- Ocata Therapeutics (NASDAQ:OCAT): Q2 EPS of -$0.20 misses by $0.01.
Nov. 7, 2014, 9:39 AM
- Advanced Cell Technology (OTCQB:ACTC) will report Q3 results on November 10 after the close. The conference call will begin at 4:30 pm ET.
Ocata Therapeutics Inc is a clinical stage biotechnology company in development & commercialization of Regenerative Ophthalmology therapeutics for Stargardt's macular degeneration, dry age-related macular degeneration, & myopic macular degeneration.
Other News & PR